Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Fresenius Delivers First US Biosimilar Approval
Kabi Receives Long-Awaited Nod From FDA For Stimufend Version Of Pegfilgrastim
Sep 07 2022
•
By
David Wallace
Fresenius Kabi has its first US biosimilar approval • Source: Shutterstock
More from Biosimilars
More from Products